Labile aggregation stimulating substance, free fatty acids, and platelet aggregation.

Area of Science:

• Biochemistry
• Hematology
• Cell Biology

Background:

• Labile aggregation stimulating substance (LASS) is an intermediate in platelet prostaglandin synthesis.
• LASS promotes platelet aggregation and release reactions, acting as an intercellular messenger.
• LASS can be generated from platelet microsomes and arachidonate.

Purpose of the Study:

• To investigate the effect of various fatty acids on LASS production and platelet aggregation.
• To determine how fatty acid composition influences platelet reactivity.

Main Methods:

• Incubation of platelet microsomes with arachidonate and varying concentrations of fatty acids.
• Measurement of subsequent platelet aggregation.
• Analysis of the mechanism of inhibition and enhancement by specific fatty acids.

Main Results:

• Polyunsaturated fatty acids, like linoleate, significantly inhibited platelet aggregation by affecting LASS production.
• Saturated and mono-unsaturated fatty acids had no effect at low concentrations but inhibited at higher concentrations.
• Stearic acid enhanced platelet aggregation by acting directly on platelets, not LASS production.

Conclusions:

• Small alterations in platelet phospholipid fatty acid composition can significantly modulate platelet aggregation.
• Fatty acids play a crucial role in regulating platelet function through interactions with LASS production and platelet activity.